The latest announcement is out from Clover Health Investments (CLOV).
Clover Health Investments, Corp. has announced the appointment of Peter Kuipers as the new Chief Financial Officer, effective after the company files its quarterly report for Q1 2024. Kuipers, an experienced financial executive with a history at Omnicell, Inc. and other notable firms, will take over from interim CFO Terrence Ronan. In his new role, Kuipers will earn a base salary of $525,000, with potential bonuses and stock options, and will also benefit from the company’s executive indemnification agreement. This strategic move is set to bolster Clover Health’s financial leadership as they continue to navigate the complex healthcare technology market.
Learn more about CLOV stock on TipRanks’ Stock Analysis page.
